The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Nea 13 Gp, Ltd since year 2005.
The trader's CIK number is 1460751.
At the time of this reporting, Nea 13 Gp, Ltd is the 10% Owner of Rhythm Pharmaceuticals, Inc. .
(stock ticker symbol RYTM).
See this page for all insider trading activities at Rhythm Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-10-10||RYTM||Rhythm Pharmaceuticals, Inc.||Buy||550,000||17.00||9,350,000|
|2016-10-31||RARX||Ra Pharmaceuticals, Inc.||Buy||338,462||13.00||4,400,006|
|2016-10-31||RARX||Ra Pharmaceuticals, Inc.||Sale||435||13.00||5,655|
|2014-07-22||ROKA||Roka Bioscience, Inc.||Buy||383,333||12.00||4,599,996|
|2013-04-16||OMTH||Omthera Pharmaceuticals, Inc.||Buy||625,000||8.00||5,000,000|
|2013-04-16||OMTH||Omthera Pharmaceuticals, Inc.||Sale||196||8.00||1,568|
|2012-10-29||MM||Millennial Media Inc.||Sale||1,597,787||13.44||21,479,050|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nea 13 Gp, Ltd (10% Owner of Rhythm Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.